This document discusses virtual ligand screening (VLS) as an alternative to high-throughput screening for identifying potential drug candidates. It describes the VLS process, which involves selecting a target and compound library, preparing the target and ligands, running a docking simulation to analyze ligand-target binding, and prioritizing hits. The document outlines advantages of computational methods like VLS compared to experimental screening, as well as some limitations. It also provides examples of free and commercial docking engines that can be used and highlights challenges in VLS like accounting for receptor flexibility.